Pravastatin reduces restenosis after coronary angioplasty of high grade stenotic lesions: Results of SHIPS (SHIga Pravastatin Study)

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cardiovascular Drugs and Therapy

• Publication date

  1996-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF00051114PMID 8924063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

  2000cited by this paper
• Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction.

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty.

  1994cited by this paper
• Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.

  1994cited by this paper
• Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.

  1994cited by this paper
• Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients.

  1993cited by this paper
• Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty A Multicenter Randomized Double‐Blind Placebo‐Controlled Trial

  1993cited by this paper
• Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.

  1993cited by this paper
• Comparison of the short-term efficacy and tolerability of lovastatin and pravastatin in the management of primary hypercholesterolemia.

  1992cited by this paper
• Does the New Angiotensin Converting Enzyme Inhibitor Cilazapril Prevent Restenosis After Percutaneous Transluminal Coronary Angioplast?: Results of the MERCATOR Study A Multicenter, Randomized, Double‐Blind Placebo‐Controlled Trial

  1992cited by this paper
• Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angiopla

  1992cited by this paper
• Prevention of Restenosis by Lovastatin After Successful Coronary Angioplasty

  1992influential reference
• Regulation of intracellular actin polymerization by prenylated cellular proteins

  1992cited by this paper
• Effect of lovastatin on intimal hyperplasia after balloon angioplasty: a study in an atherosclerotic hypercholesterolemic rabbit.

  1991cited by this paper
• Prevention of restenosis by lovastatin after successful coronary angioplasty.

  1991cited by this paper
• Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

  1990cited by this paper
• Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty.

  1990cited by this paper
• A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group.

  1990cited by this paper
• Randomised trial of fish oil for prevention of restenosis after coronary angioplasty.

  1989cited by this paper
• Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry.

  1988cited by this paper
• Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients.

  1988influential reference
• Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

  1988cited by this paper
• Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience.

  1987cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper
• Quantitative analysis of coronary arteriograms by microprocessor cinevideodensitometry.

  1987cited by this paper
• Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty.

  1986cited by this paper
• Restenosis after successful coronary angioplasty in patients with single-vessel disease.

  1986cited by this paper
• Comparative results of percutaneous transluminal coronary angioplasty in patients with dynamic versus fixed coronary stenosis.

  1986cited by this paper
• [Percutaneous transluminal coronary angioplasty].

  1985cited by this paper
• Coronary angioplasty: clinical and angiographic follow-up.

  1985cited by this paper
• Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.

  1985cited by this paper
• Recurrence rate after successful coronary angioplasty.

  1985cited by this paper
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

  1984cited by this paper
• Quantification of relative coronary arterial stenosis by cinevideodensitometric analysis of coronary arteriograms.

  1984cited by this paper
• Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?

  1984cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

  1984cited by this paper
• Confidentiality and under-age girls who seek contraceptive advice.

  1983cited by this paper
• Observer Agreement in Evaluating Coronary Angiograms

  1975cited by this paper
• A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

  1975cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• 2-Methylpropan-2-ammonium [(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-heptanoate

  2024cites this paper
• Pravastatin for lowering lipids.

  2020cites this paper
• Effects of Statin Treatment on Early Outcomes and Restenosis after Carotid Stenting

  2014cites this paper
• Systematic review and meta‐analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present

  2007cites this paper
• HEART's Original [臨床研究] 冠インターベンション前後の血清脂質値が急性冠症候群症例の再狭窄におよぼす影響

  2006cites this paper
• Effect of Statin Therapy on Arterial Stiffness in Patients with Hyperlipidemia:Shiga Pravastatin Atherosclerosis Study (SHIPAS) Group

  2005cites this paper
• Use of fluvastatin following percutaneous coronary intervention

  2005cites this paper
• Effects of statins on vascular structure and function: a systematic review.

  2004cites this paper
• WHAT HAVE WE LEARNED FROM 10 YEARS PERIPHERAL INTRAVASCULAR ULTRASOUND

  2003cites this paper
• Angiotensinogen M235T gene polymorphism and recurrent restenosis after repeated percutaneous transluminal coronary angiography.

  2002cites this paper
• Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury.

  2000cites this paper
• Effect of simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction.

  2000cites this paper
• Lipid-lowering therapy after coronary revascularization.

  2000cites this paper
• Lipid-lowering therapy after coronary revascularization: the interventional cardiologist's perspective.

  1998cites this paper
• [Mechanisms and prevention of restenosis after coronary angioplasty].

  1998cites this paper
• Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials?

  1998cites this paper